Aciont Inc. is a mid-clinical staged, specialty biopharmaceutical company located in Salt Lake City, Utah.  Our Visulex noninvasive drug delivery technology platforms endeavor to advance therapeutics in ophthalmology.  Our world renowned research team is focused on developing noninvasive therapeutics for sight threatening diseases of both the anterior and posterior sections of the eye addressing a potential wide range of ocular diseases requiring therapies with drug transport and controlled release challenges.   Our lead clinical staged product, DSP Visulex, addresses key ocular inflammation related indications such as severe uveitis, post operative pain/inflammation and macular edema.   

See the latest news and corporate updates.

Review our mission statement and profiles of Aciont's leadership and advisory team.

See references to relevant peer reviewed publications and research materials.

See where Aciont will be presenting in the near future.   用中文(表达

Please contact us if you share an interest in our mission to advance ocular therapeutics.